vs
Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and Xometry, Inc. (XMTR). Click either name above to swap in a different company.
Xometry, Inc. is the larger business by last-quarter revenue ($192.4M vs $148.5M, roughly 1.3× OPKO HEALTH, INC.). Xometry, Inc. runs the higher net margin — -4.5% vs -21.1%, a 16.6% gap on every dollar of revenue. On growth, Xometry, Inc. posted the faster year-over-year revenue change (29.5% vs -19.2%). Xometry, Inc. produced more free cash flow last quarter ($-5.9M vs $-28.6M). Over the past eight quarters, Xometry, Inc.'s revenue compounded faster (25.2% CAGR vs -7.5%).
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
Xometry is an online marketplace for sourcing on-demand manufactured parts for prototyping and large-scale production.
OPK vs XMTR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.5M | $192.4M |
| Net Profit | $-31.3M | $-8.6M |
| Gross Margin | 43.1% | 39.1% |
| Operating Margin | -25.8% | -4.6% |
| Net Margin | -21.1% | -4.5% |
| Revenue YoY | -19.2% | 29.5% |
| Net Profit YoY | -322.8% | 12.7% |
| EPS (diluted) | $-0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.5M | $192.4M | ||
| Q3 25 | $151.7M | $180.7M | ||
| Q2 25 | $156.8M | $162.5M | ||
| Q1 25 | $150.0M | $151.0M | ||
| Q4 24 | $183.6M | $148.5M | ||
| Q3 24 | $173.6M | $141.7M | ||
| Q2 24 | $182.2M | $132.6M | ||
| Q1 24 | $173.7M | $122.7M |
| Q4 25 | $-31.3M | $-8.6M | ||
| Q3 25 | $21.6M | $-11.6M | ||
| Q2 25 | $-148.4M | $-26.4M | ||
| Q1 25 | $-67.6M | $-15.1M | ||
| Q4 24 | $14.0M | $-9.9M | ||
| Q3 24 | $24.9M | $-10.2M | ||
| Q2 24 | $-10.3M | $-13.7M | ||
| Q1 24 | $-81.8M | $-16.6M |
| Q4 25 | 43.1% | 39.1% | ||
| Q3 25 | 32.9% | 39.9% | ||
| Q2 25 | 31.5% | 40.1% | ||
| Q1 25 | 28.4% | 37.3% | ||
| Q4 24 | 46.1% | 39.7% | ||
| Q3 24 | 23.1% | 39.4% | ||
| Q2 24 | 28.4% | 39.9% | ||
| Q1 24 | 24.2% | 39.0% |
| Q4 25 | -25.8% | -4.6% | ||
| Q3 25 | 31.7% | -6.1% | ||
| Q2 25 | -38.3% | -6.3% | ||
| Q1 25 | -44.8% | -10.2% | ||
| Q4 24 | -18.0% | -7.8% | ||
| Q3 24 | 8.2% | -8.1% | ||
| Q2 24 | -33.9% | -11.5% | ||
| Q1 24 | -41.2% | -14.6% |
| Q4 25 | -21.1% | -4.5% | ||
| Q3 25 | 14.3% | -6.4% | ||
| Q2 25 | -94.7% | -16.3% | ||
| Q1 25 | -45.1% | -10.0% | ||
| Q4 24 | 7.6% | -6.7% | ||
| Q3 24 | 14.3% | -7.2% | ||
| Q2 24 | -5.7% | -10.3% | ||
| Q1 24 | -47.1% | -13.5% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $-0.19 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.03 | — | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $364.4M | $219.1M |
| Total DebtLower is stronger | $344.0M | — |
| Stockholders' EquityBook value | $1.3B | $275.6M |
| Total Assets | $1.9B | $703.7M |
| Debt / EquityLower = less leverage | 0.27× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $364.4M | $219.1M | ||
| Q3 25 | $412.0M | $224.5M | ||
| Q2 25 | $267.3M | $225.8M | ||
| Q1 25 | $428.8M | $231.4M | ||
| Q4 24 | $426.6M | $239.8M | ||
| Q3 24 | $400.1M | $234.0M | ||
| Q2 24 | $40.6M | $240.9M | ||
| Q1 24 | $75.6M | $253.8M |
| Q4 25 | $344.0M | — | ||
| Q3 25 | $344.2M | — | ||
| Q2 25 | $343.3M | — | ||
| Q1 25 | $439.2M | — | ||
| Q4 24 | $437.2M | — | ||
| Q3 24 | $441.0M | — | ||
| Q2 24 | $201.9M | — | ||
| Q1 24 | $350.1M | — |
| Q4 25 | $1.3B | $275.6M | ||
| Q3 25 | $1.3B | $272.0M | ||
| Q2 25 | $1.3B | $270.4M | ||
| Q1 25 | $1.3B | $309.9M | ||
| Q4 24 | $1.4B | $314.5M | ||
| Q3 24 | $1.4B | $315.2M | ||
| Q2 24 | $1.4B | $315.8M | ||
| Q1 24 | $1.3B | $320.4M |
| Q4 25 | $1.9B | $703.7M | ||
| Q3 25 | $2.0B | $698.9M | ||
| Q2 25 | $2.0B | $687.0M | ||
| Q1 25 | $2.1B | $690.1M | ||
| Q4 24 | $2.2B | $680.1M | ||
| Q3 24 | $2.3B | $678.2M | ||
| Q2 24 | $2.0B | $678.6M | ||
| Q1 24 | $2.0B | $692.5M |
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.9M | $4.4M |
| Free Cash FlowOCF − Capex | $-28.6M | $-5.9M |
| FCF MarginFCF / Revenue | -19.3% | -3.0% |
| Capex IntensityCapex / Revenue | 1.8% | 5.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-190.8M | $-24.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.9M | $4.4M | ||
| Q3 25 | $-34.6M | $5.8M | ||
| Q2 25 | $-83.4M | $-427.0K | ||
| Q1 25 | $-34.6M | $-3.7M | ||
| Q4 24 | $-44.4M | $9.1M | ||
| Q3 24 | $-77.1M | $-3.6M | ||
| Q2 24 | $-26.4M | $-9.1M | ||
| Q1 24 | $-35.6M | $-11.7M |
| Q4 25 | $-28.6M | $-5.9M | ||
| Q3 25 | $-37.8M | $-1.7M | ||
| Q2 25 | $-86.7M | $-7.4M | ||
| Q1 25 | $-37.7M | $-9.2M | ||
| Q4 24 | $-49.8M | $4.5M | ||
| Q3 24 | $-85.0M | $-8.4M | ||
| Q2 24 | $-33.7M | $-13.5M | ||
| Q1 24 | $-40.0M | $-16.1M |
| Q4 25 | -19.3% | -3.0% | ||
| Q3 25 | -24.9% | -0.9% | ||
| Q2 25 | -55.3% | -4.5% | ||
| Q1 25 | -25.2% | -6.1% | ||
| Q4 24 | -27.1% | 3.1% | ||
| Q3 24 | -49.0% | -6.0% | ||
| Q2 24 | -18.5% | -10.2% | ||
| Q1 24 | -23.0% | -13.1% |
| Q4 25 | 1.8% | 5.3% | ||
| Q3 25 | 2.1% | 4.1% | ||
| Q2 25 | 2.1% | 4.3% | ||
| Q1 25 | 2.1% | 3.6% | ||
| Q4 24 | 2.9% | 3.1% | ||
| Q3 24 | 4.6% | 3.4% | ||
| Q2 24 | 4.0% | 3.3% | ||
| Q1 24 | 2.6% | 3.5% |
| Q4 25 | — | — | ||
| Q3 25 | -1.60× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.17× | — | ||
| Q3 24 | -3.10× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
XMTR
| US | $159.1M | 83% |
| Non Us | $33.3M | 17% |
